The Goods and Services Tax Council after its 50th meet in New Delhi on Tuesday has agreed to exempt GST on import of cancer drug Dinutuximab, and Food for Special Medical Purposes (FSMP) used in the treatment of rare diseases. Currently, the drug attracts a 12% integrated GST.
Recent Posts
- Iran accuses US of violating ceasefire with new attacks
- Countries scramble to track virus-affected cruise passengers
- FM launches new insurance policy for manufacturers
- Iran sets Hormuz transit rules; Shipowners stay cautious
- Banks must prepare for cyber threats posed by AI models like Mythos: Nagaraju
Categories
- Articles
- Banking & Bancassurance
- Blog
- Breaking News!
- Briefs
- Climate, Environment, Renewable Energy
- Data
- Disaster & Management
- Eco/Invest/Demography
- Editorial
- Events
- Facts
- Features
- Health
- Indian News
- Intermediaries
- International News
- Interviews
- Life
- Main Menu
- Non-Life
- Pandemic
- Pension & Social Security
- Policy
- Regulation
- Reinsurance
- Risk Management
- Simple
- Technology
- Trends, Facts
- Uncategorized
- Wealth Management/ Philanthropy
- Workplace/Employee Benefits